Cite
MLA Citation
Anthony Marson et al.. “The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.” Lancet, vol. 397, no. 10282, 2021, pp. 1375–1386. http://access.bl.uk/ark:/81055/vdc_100159421125.0x00004e